{"transactions":[{"id":4636981,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-10-07T20:09:10.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24655,"price":5,"value":123275.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":47682,"source":{"system":"sec-edgar","filing":"0001447028-26-000058","document":"wk-form4_1791403746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000058/wk-form4_1791403746.xml","form_type":"4"}},{"id":4625871,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":10456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 71,700 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":61244,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":10456},"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625870,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":116408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 310,422 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 18, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":194014,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":116408},"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625869,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":82527,"price":5.07,"value":418411.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 82,527 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":72337,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625868,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":10456,"price":4.39,"value":45901.84,"ownership":{"direct":true},"balance_after":154864,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":4625867,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-09-24T00:32:24.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":116408,"price":3.2,"value":372505.6,"ownership":{"direct":true},"balance_after":144408,"source":{"system":"sec-edgar","filing":"0001447028-26-000053","document":"wk-form4_1790209942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1936604/000144702826000053/wk-form4_1790209942.xml","form_type":"4"}},{"id":924840,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T01:21:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":71700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":71700,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":71700},"source":{"system":"sec-edgar","filing":"0001447028-26-000008","document":"wk-form4_1770081671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000008/wk-form4_1770081671.xml","form_type":"4"}},{"id":924839,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Shares","published_at":"2026-02-03T01:21:13.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001447028-26-000008","document":"wk-form4_1770081671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702826000008/wk-form4_1770081671.xml","form_type":"4"}},{"id":1195597,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-20T20:08:32.000Z","date":"2025-03-18","kind":"grant","planned":false,"acquired":true,"shares":310422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":310422,"derivative":{"exercise_price":3.2,"expiration_date":"2035-03-18","underlying":"Common Shares","underlying_shares":310422},"source":{"system":"sec-edgar","filing":"0001447028-25-000072","document":"wk-form4_1742501306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1447028/000144702825000072/wk-form4_1742501306.xml","form_type":"4"}},{"id":1293346,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-28T22:35:27.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the Reporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001104659-25-006782","document":"tm254730-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006782/tm254730-2_4seq1.xml","form_type":"4"}},{"id":1293345,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-28T22:35:27.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15750,"source":{"system":"sec-edgar","filing":"0001104659-25-006782","document":"tm254730-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465925006782/tm254730-2_4seq1.xml","form_type":"4"}},{"id":1385140,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T20:01:56.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This restricted stock grant was made pursuant to the Issuer's 2018 Equity Incentive Plan and vests as to 50% of the shares on October 16, 2025 and in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001104659-24-109524","document":"tm2426349-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924109524/tm2426349-4_4seq1.xml","form_type":"4"}},{"id":1669874,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-01-26T21:32:33.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the\nReporting Person's continuous service to the Issuer through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as to 50% on the first anniversary of January 24, 2024 and, as to the remaining amount, in two equal annual installments thereafter, subject to the\nReporting Person's continuous service to the Issuer through each applicable vesting date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-24-007291","document":"tm244260-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465924007291/tm244260-2_4seq1.xml","form_type":"4"}},{"id":2040580,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-01-31T21:07:15.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date."}],"balance_after":2859,"derivative":{"exercise_price":4,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001104659-23-008597","document":"tm234943-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465923008597/tm234943-1_4seq1.xml","form_type":"4"}},{"id":2212503,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":68206,"kind":"person","name":"Androski Lindsay","position":1,"cik":"0001936604","reported_name":"Androski Lindsay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-07-07T01:50:36.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 50% of the underlying shares on July 1, 2023 and the remainder in twelve (12) equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":0.25,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-077837","document":"tm2220578-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922077837/tm2220578-1_4seq1.xml","form_type":"4"}}]}